Use of proton magnetic resonance spectroscopy of the brain to differentiate gliomatosis cerebri from low-grade glioma.
about
In vivo magnetic resonance spectroscopy: basic methodology and clinical applicationsGliomatosis cerebri: a review.Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and meta-analysis.Utility of functional diffusion maps to monitor a patient diagnosed with gliomatosis cerebri.Quantitative short echo time 1H MRSI of the peripheral edematous region of human brain tumors in the differentiation between glioblastoma, metastasis, and meningioma.Spatially quantifying microscopic tumor invasion and proliferation using a voxel-wise solution to a glioma growth model and serial diffusion MRISurvival analysis in patients with newly diagnosed glioblastoma using pre- and postradiotherapy MR spectroscopic imaging.High-resolution magic angle spinning magnetic resonance spectroscopy detects glycine as a biomarker in brain tumors.Differential diagnosis of white matter lesions: Nonvascular causes-Part II.Heterogeneity in malignant gliomas: a magnetic resonance analysis of spatial distribution of metabolite changes and regional blood volume.Stripe-like increase of rCBV beyond the visible border of glioblastomas: site of tumor infiltration growing after neurosurgery.(1)H MR Spectroscopy in Gliomatosis: Is there a Sensitivity Issue?Prognostic factors for patients with gliomatosis cerebri: retrospective analysis of 17 consecutive cases.(1)H MRSI and progression-free survival in patients with WHO grades II and III gliomas.Recognition of anaplastic foci within low-grade gliomas using MR spectroscopy.In vivo NMR studies of regional cerebral energetics in MPTP model of Parkinson's disease: recovery of cerebral metabolism with acute levodopa treatment.Spectroscopy imaging in intraoperative MR suite: tissue characterization and optimization of tumor resection.Five-Year Longitudinal MRI Follow-up and (1)H Single Voxel MRS in 14 patients with Gliomatosis Treated with Temodal, Radiotherapy and Antiangiogenic Therapy.
P2860
Q30482507-047D3DDD-185E-4E74-8B12-C1F25499B9D5Q30726280-4D121045-BABA-4068-AF08-413D7B812E48Q31001850-488F4D61-F6D1-4D99-AAD3-1B2D9B5C45D1Q34206891-7854016E-3DD7-4938-B437-7AB28C340E07Q34320779-4C66329D-56FD-4A70-BD42-C527BD42BF1FQ34731176-9BC0DC14-3F24-4C44-BACE-0A796A68F186Q36792743-AA9EDB2A-0150-4F3E-A5A4-CD6FB463C448Q37024727-28437C9E-97F7-4864-AC2F-98807A8C1941Q38187363-98168574-A92B-407F-8B90-9ECE19AC9432Q39819218-61F06018-DA33-40C2-B162-0D81A1AE73ECQ39829938-0BABAF6A-B7A0-47F3-8BA0-FC6468B879DBQ42158059-59C42BCA-B9C8-4E88-80FB-F13FBBB706C9Q42752134-AF0BA232-E79A-4408-93D1-276AA37CFB4AQ43281961-0691A97C-E7E3-47CF-91F3-51FBB3665F84Q43413739-9462F005-E78D-43BB-B4A7-6D76634DD473Q43549901-DE9E3F60-08DA-46D2-B219-664D138E72F6Q46623342-BD4598D0-FDB3-4AD3-8BC2-4FCB6B0A33CFQ49118260-DC3D2477-57BC-47B1-B9F9-DF3F20FF6EE5
P2860
Use of proton magnetic resonance spectroscopy of the brain to differentiate gliomatosis cerebri from low-grade glioma.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Use of proton magnetic resonan ...... cerebri from low-grade glioma.
@en
Use of proton magnetic resonan ...... cerebri from low-grade glioma.
@nl
type
label
Use of proton magnetic resonan ...... cerebri from low-grade glioma.
@en
Use of proton magnetic resonan ...... cerebri from low-grade glioma.
@nl
prefLabel
Use of proton magnetic resonan ...... cerebri from low-grade glioma.
@en
Use of proton magnetic resonan ...... cerebri from low-grade glioma.
@nl
P2093
P50
P1476
Use of proton magnetic resonan ...... cerebri from low-grade glioma.
@en
P2093
Damien Galanaud
François Nicoli
Jean-Philippe Ranjeva
Maryline Barrie-Attarian
Olivier Chinot
Patrick J Cozzone
Patrick Viout
Stéphane Fuentès
Sylviane Confort-Gouny
Yann Le Fur
P304
P356
10.3171/JNS.2003.98.2.0269
P407
P577
2003-02-01T00:00:00Z